Nitric oxide, a communicator between tumor cells and endothelial cells, mediates the anti-tumor effects of Marsdenia Tenacissima Extract (MTE)

被引:9
作者
Li, Zhandong [1 ]
Hao, Huifeng [1 ]
Tian, Wenjia [2 ]
Jiao, Yanna [1 ]
Deng, Xinxin [3 ]
Han, Shuyan [1 ]
Han, Jingyan [4 ]
机构
[1] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Integrat Chinese & Western Med, Minist Educ,Canc Hosp & Inst, Beijing 100142, Peoples R China
[2] Peking Univ, Int Hosp, Dept Gastroenterol, Beijing 102206, Peoples R China
[3] Ningxia Med Univ, Ningxia Res Ctr Modern Hui Med Engn & Technol, Key Lab Hui Ethn Med Modernizat, Minist Educ,Pharm Coll, Yinchuan 750004, Ningxia, Peoples R China
[4] Peking Univ, Hlth Sci Ctr, Dept Integrat Chinese & Western Med, Tasly Microcirculat Res Ctr, 38 Xue Yuan Rd, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
Traditional Chinese medicine; Lung cancer; Tumor microenvironment; Endothelial cells; PICA; S-NITROSYLATION; IN-VITRO; ANGIOGENESIS; APOPTOSIS; GROWTH; SENSITIVITY; INHIBITION; SURVIVIN;
D O I
10.1016/j.jep.2019.112524
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Marsdenia tenacissima (Roxb.) Wight & Arn is a well-known traditional Chinese medicine for treating cancer. The anti-tumor effects of the water soluble component of M. tenacissima (MTE, M. 7'enacissima Extract) have been intensely studied. However, the roles of microenvironmental cells in mediating the anti-tumor actions of MTE remain to be defined. Aim of the study: To determine the roles of nitric oxide (NO) released by endothelial cells (ECs), an important component of tumor microenvironment, in regulating the anti-cancer effects of MTE, and to explore the underlying mechanisms. Materials and methods: Co-culture system of ECs and A549 non-small cell lung cancer (NSCLC) cells was established for determining the interactions of ECs and lung cancer cells. Nitro-L-arginine methyl ester hydrochloride (L-NAME) was used to inhibit the production of NO. Cell viability was examined using cell counting kit 8 and 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay. NO assay and Western blot were used to determine the involved signaling pathway. Primary lung microenvironmental cells (PLMCs) were cultured to examine the roles of NO released from the lung microenvironment in regulating the anti-cancer effects of MTE. A subcutaneous xenograft model was established to determine the involvement of NO in effects of MTE against NSCLCs in vivo. Results: In the co-culture system of ECs and A549 NSCLC cells, MTE (30 mg/mL) treatment reduced viability of lung cancer cells. However, when L-NAME (a nitric oxide synthase (NOS) inhibitor, 300 mu M) was introduced into the co-culture system, the NSCLC-inhibiting effects of MTE were significantly suppressed. By contrast, addition of L-NAME (300 mu M) did not affect the anti-cancer efficiency of MTE when ECs were not present. Mechanistically, MTE enhanced endothelial production of NO via stimulating PKA-endothelial nitric oxide synthase (eNOS) signaling. Elevated levels of NO inhibited proliferation and promoted apoptosis of the A549 NSCLC cells. Importantly, PKA-eNOS-NO signaling was effective in mediating the anti-cancer effects of MTE, when lung cancer cells were co-cultured with PLMCs. Finally, oral administration of MTE to the subcutaneous xenograft mice significantly suppressed tumor growth, while elevated NO productions. Plasma NO was also revealed to be negatively correlated with the tumor weight. Conclusions: ECs significantly contributed to anti-cancer effects of MTE by elevating production of NO, in a PKA- dependent manner. The present study revealed a novel anti-cancer mechanism of MTE through regulating the function of ECs, an important component of tumor microenvironment.
引用
收藏
页数:9
相关论文
共 40 条
  • [1] The lung microenvironment: an important regulator of tumour growth and metastasis
    Altorki, Nasser K.
    Markowitz, Geoffrey J.
    Gao, Dingcheng
    Port, Jeffrey L.
    Saxena, Ashish
    Stiles, Brendon
    McGraw, Timothy
    Mittal, Vivek
    [J]. NATURE REVIEWS CANCER, 2019, 19 (01) : 9 - 31
  • [2] Plasminogen Activator Inhibitor-1 Antagonist TM5441 Attenuates Nω-Nitro-L-Arginine Methyl Ester-Induced Hypertension and Vascular Senescence
    Boe, Amanda E.
    Eren, Mesut
    Murphy, Sheila B.
    Kamide, Christine E.
    Ichimura, Atsuhiko
    Terry, David
    McAnally, Danielle
    Smith, Layton H.
    Miyata, Toshio
    Vaughan, Douglas E.
    [J]. CIRCULATION, 2013, 128 (21) : 2318 - 2324
  • [3] Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination
    Chanvorachote, Pithi
    Nimmannit, Ubonthip
    Stehlik, Christian
    Wang, Liying
    Jiang, Bing-Hua
    Ongpipatanakul, Boonsri
    Rojanasakul, Yon
    [J]. CANCER RESEARCH, 2006, 66 (12) : 6353 - 6360
  • [4] Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells
    Chao, JI
    Kuo, PC
    Hsu, TS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) : 20267 - 20276
  • [5] Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial
    Cunningham, David
    Stenning, Sally P.
    Smyth, Elizabeth C.
    Okines, Alicia F.
    Allum, William H.
    Rowley, Sam
    Stevenson, Laura
    Grabsch, Heike I.
    Alderson, Derek
    Crosby, Thomas
    Griffin, S. Michael
    Mansoor, Wasat
    Coxon, Fareeda Y.
    Falk, Stephen J.
    Darby, Suzanne
    Sumpter, Kate A.
    Blazeby, Jane M.
    Langley, Ruth E.
    [J]. LANCET ONCOLOGY, 2017, 18 (03) : 357 - 370
  • [6] Marsdenia tenacissima extract suppresses tumor growth and angiogenesis in A20 mouse lymphoma
    Dai, Xingbin
    Ji, Yanhua
    Jiang, Pengjun
    Sun, Xuemei
    [J]. ONCOLOGY LETTERS, 2017, 13 (05) : 2897 - 2902
  • [7] NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas
    Engels, Knut
    Knauer, Shirley K.
    Loibl, Sibylle
    Fetz, Verena
    Harter, Philipp
    Schweitzer, Andrea
    Fisseler-Eckhoff, Annette
    Kommoss, Friedrich
    Hanker, Lars
    Nekljudova, Valentina
    Hermanns, Iris
    Kleinert, Hartmut
    Mann, Wolf
    du Bois, Andreas
    Stauber, Roland H.
    [J]. CANCER RESEARCH, 2008, 68 (13) : 5159 - 5166
  • [8] Feger F, 2001, CANCER RES, V61, P5289
  • [9] Nitric oxide synthases: regulation and function
    Foerstermann, Ulrich
    Sessa, William C.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (07) : 829 - +
  • [10] FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182